Using a FLCN-deficient kidney model, it was found that FLCN loss upregulates PGC1α expression, which results in elevated mitochondrial function and oxidative metabolism in renal cancer cells (Hasumi et al., 2012). This evidence concerns the gene FLCN and renal carcinoma.